Expertise, Role and Activity
At EMC, the Rotterdam Study, an observational population-based cohort study, started in 1990 and contains >17.000 individuals. The study aims to unravel etiology, preclinical course, natural history and potential targets for intervention for chronic diseases, such as atherosclerosis, in mid- and late-life.
EMC is an essential consortium partner to study biomarkers for CVD, as all relevant clinical parameters and blood/serum samples from a large general population cohort taken over the years are available, required for WP3, in close collaboration with ULUND.
With the Rotterdam study, B-specific consortium will be able to critically assess the predictive values of potential biomarkers for atherosclerosis.
The team at EMC is composed of 3 PIs, their expertise is vital for the execution of WP4 of B-specific.
Maryam Kavousi
Dr. Maryam Kavousi - expert in the field of cardiovascular epidemiology
Arkan Ikram
Dr. Arkan Ikram - expert in epidemiology
Joyce van Meurs
Prof. Joyce van Meurs - expert on integrative genomics in population cohorts
Dylan Maassen Veeters
His expertise is in bioinformatics and his background involves immune repertoire and coronary artery disease research. He will be working with the WP3 and WP4, researching autoreactive B cell biomarkers and investigating the causality of these biomarkers using 'The Rotterdam Study'
All the Consortium
